ERAS earnings date and last-quarter result: next report 2026-08-11, last quarter miss, P/E -20.98. Updated 2026-07-23.
Erasca (ERAS) Research Hub
Erasca (ERAS) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 14.99 USD (+4.17%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -20.98, market cap 6.06B. This hub links to the full technical, earnings and options research available for ERAS.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 14.99 USD (+4.17%) |
| 52-week range | 13.1 USD – 21.6 USD |
| Trend regime | Range |
| 14-day RSI | 54.4 (Neutral) |
| Trailing P/E | -20.98 |
| Market cap | 6.06B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-11 |
Available research for ERAS
Covered Call on ERAS: how it works, illustrative setup around the real 14.99 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ERAS: how it works, illustrative setup around the real 14.99 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ERAS: how it works, illustrative setup around the real 14.99 USD price, max profit/loss, breakeven and when to use it. Educational.
ERAS technical analysis: range, last 14.99 USD, RSI 54.4, 52w range 13.1 USD–21.6 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is ERAS in?
Erasca (ERAS) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ERAS in an uptrend or downtrend?
As of 2026-10-26, ERAS is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ERAS's trailing P/E ratio?
ERAS's trailing P/E is -20.98, with a market cap of 6.06B. See the earnings research page for full valuation detail.
When does ERAS next report earnings?
ERAS is next scheduled to report earnings on 2026-08-11.